ClinicalTrials.Veeva

Menu

Evaluation of Some Biochemical Markers of Bone Turnover in Childern and Adolescents With Type 1 Diabetes

S

Sohag University

Status

Not yet enrolling

Conditions

Type 1 Diabetes

Treatments

Diagnostic Test: serum ostecalcin,serum sclerostin and parathroid profile

Study type

Observational

Funder types

Other

Identifiers

NCT05892848
Soh-Med-23-05-03MS

Details and patient eligibility

About

Type 1 diabetes is associated with many longterm complications as retinopathy,neuropathy and nephropathy. Recently, several studies have linked type 1 diabetes to bone fragility.Studies conducted on patients with type 1 diabetes have concluded that bone is negatively affected in type 1 diabetes with impaired bone density,increased fracture risk and impaired bone turnover markers.

Enrollment

100 estimated patients

Sex

All

Ages

3 to 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • childern and adolsecents below 16 years of age diagnsed with type 1 diabetes for at least 1 year age and sex-matched control childern and adolsecents will be included

Exclusion criteria

  • childern and adolescents with congenital bone disease, those with disorders of the parathyroid gland and those with chronic kidney disease.

Trial design

100 participants in 2 patient groups

cases group
Description:
childern and adolescents with type 1 diabetes
Treatment:
Diagnostic Test: serum ostecalcin,serum sclerostin and parathroid profile
control group
Description:
age and sex matched control childern and adolsecents
Treatment:
Diagnostic Test: serum ostecalcin,serum sclerostin and parathroid profile

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed M Monir, assistant professor; Hajar M Ismail, resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems